Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Estimates of protection levels against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season: the IMMUNEBRIDGE project.
Lange B, Jaeger VK, Harries M, Rücker V, Streeck H, Blaschke S, Petersmann A, Toepfner N, Nauck M, Hassenstein MJ, Dreier M, von Holt I, Budde A, Bartz A, Ortmann J, Kurosinski MA, Berner R, Borsche M, Brandhorst G, Brinkmann M, Budde K, Deckena M, Engels G, Fenzlaff M, Härtel C, Hovardovska O, Katalinic A, Kehl K, Kohls M, Krüger S, Lieb W, Meyer-Schlinkmann KM, Pischon T, Rosenkranz D, Rübsamen N, Rupp J, Schäfer C, Schattschneider M, Schlegtendal A, Schlinkert S, Schmidbauer L, Schulze-Wundling K, Störk S, Tiemann C, Völzke H, Winter T, Klein C, Liese J, Brinkmann F, Ottensmeyer PF, Reese JP, Heuschmann P, Karch A. Lange B, et al. Among authors: ottensmeyer pf. Infection. 2024 Feb;52(1):139-153. doi: 10.1007/s15010-023-02071-2. Epub 2023 Aug 2. Infection. 2024. PMID: 37530919 Free PMC article.
SARS-CoV-2 sero-immunity and quality of life in children and adolescents in relation to infections and vaccinations: the IMMUNEBRIDGE KIDS cross-sectional study, 2022.
Engels G, Oechsle AL, Schlegtendal A, Maier C, Holzwarth S, Streng A, Lange B, Karch A, Petersmann A, Streeck H, Blaschke-Steinbrecher S, Härtel C, Schroten H, von Kries R, Berner R, Liese J, Brinkmann F, Toepfner N; IMMUNEBRIDGE KIDS study group. Engels G, et al. Infection. 2023 Oct;51(5):1531-1539. doi: 10.1007/s15010-023-02052-5. Epub 2023 Jun 6. Infection. 2023. PMID: 37280412 Free PMC article.
Immunity Against SARS-CoV-2 in the German Population.
Schulze-Wundling K, Ottensmeyer PF, Meyer-Schlinkmann KM, Deckena M, Krüger S, Schlinkert S, Budde A, Münstermann D, Töpfner N, Petersmann A, Nauck M, Karch A, Lange B, Blaschke S, Tiemann C, Streeck H. Schulze-Wundling K, et al. Among authors: ottensmeyer pf. Dtsch Arztebl Int. 2023 May 12;120(19):337-344. doi: 10.3238/arztebl.m2023.0072. Dtsch Arztebl Int. 2023. PMID: 37155224 Free PMC article.
SARS-CoV-2 in Environmental Samples of Quarantined Households.
Döhla M, Schulte B, Wilbring G, Kümmerer BM, Döhla C, Sib E, Richter E, Ottensmeyer PF, Haag A, Engelhart S, Eis-Hübinger AM, Exner M, Mutters NT, Schmithausen RM, Streeck H. Döhla M, et al. Among authors: ottensmeyer pf. Viruses. 2022 May 17;14(5):1075. doi: 10.3390/v14051075. Viruses. 2022. PMID: 35632816 Free PMC article.
[Evaluating the introduction of HIV pre-exposure prophylaxis as a benefit of statutory health insurance (EvE-PrEP) : Highly effective protection against HIV without an increase in sexually transmitted infections].
Schmidt D, Kollan C, Schewe K, Hanhoff N, Rüsenberg R, Friebe M, Schikowski T, Schink SB, Marcus U, Koppe U, Jansen K, Streeck H, Ottensmeyer P, An der Heiden M, Bannert N, M'Bayo R, Ceres M, Weber L, Sweers H, Schmidt AJ, Tietz H, Danan E, Bendig J, Kloep S, Neumann A, Valbert F, Wasem J, Bartmeyer B, Bremer V; NEPOS Studiengruppe. Schmidt D, et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023 Sep;66(9):1008-1018. doi: 10.1007/s00103-023-03733-0. Epub 2023 Jul 12. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023. PMID: 37436444 Free PMC article. German.